ATE81974T1 - Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums. - Google Patents

Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums.

Info

Publication number
ATE81974T1
ATE81974T1 AT88106677T AT88106677T ATE81974T1 AT E81974 T1 ATE81974 T1 AT E81974T1 AT 88106677 T AT88106677 T AT 88106677T AT 88106677 T AT88106677 T AT 88106677T AT E81974 T1 ATE81974 T1 AT E81974T1
Authority
AT
Austria
Prior art keywords
imidazoline
pyridyl
phenyl
ethyl
salt
Prior art date
Application number
AT88106677T
Other languages
English (en)
Inventor
Yasumasa Yoshie
Setsuo Kobayashi
Tsugio Nakazawa
Yasushi Abiko
Kinya Kameda
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE81974T1 publication Critical patent/ATE81974T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT88106677T 1987-04-27 1988-04-26 Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums. ATE81974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10372787 1987-04-27
EP88106677A EP0288978B1 (de) 1987-04-27 1988-04-26 Verwendung von 2-[2-Phenyl-2-(2-pyridyl)]ethyl-2-imidazolin oder eines Salzes davon zur Herstellung eines Antiasthmatikums

Publications (1)

Publication Number Publication Date
ATE81974T1 true ATE81974T1 (de) 1992-11-15

Family

ID=14361688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88106677T ATE81974T1 (de) 1987-04-27 1988-04-26 Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums.

Country Status (15)

Country Link
US (1) US4874772A (de)
EP (1) EP0288978B1 (de)
KR (1) KR880012228A (de)
AT (1) ATE81974T1 (de)
AU (1) AU611145B2 (de)
CA (1) CA1309027C (de)
DE (1) DE3875647T2 (de)
DK (1) DK226688A (de)
ES (1) ES2052634T3 (de)
GR (1) GR3006610T3 (de)
HU (1) HU203665B (de)
IL (1) IL86151A (de)
NO (1) NO881798L (de)
PH (1) PH24155A (de)
ZA (1) ZA882737B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936885B2 (ja) * 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤
JPS60123418A (ja) * 1983-12-07 1985-07-02 Dai Ichi Seiyaku Co Ltd 血管拡張剤

Also Published As

Publication number Publication date
DE3875647D1 (de) 1992-12-10
KR880012228A (ko) 1988-11-26
NO881798D0 (no) 1988-04-25
NO881798L (no) 1988-10-28
AU1519088A (en) 1988-10-27
EP0288978A2 (de) 1988-11-02
HUT46537A (en) 1988-11-28
PH24155A (en) 1990-03-22
ES2052634T3 (es) 1994-07-16
DE3875647T2 (de) 1993-03-18
AU611145B2 (en) 1991-06-06
DK226688D0 (da) 1988-04-26
ZA882737B (en) 1988-10-17
IL86151A (en) 1993-04-04
US4874772A (en) 1989-10-17
HU203665B (en) 1991-09-30
EP0288978A3 (en) 1990-02-21
GR3006610T3 (de) 1993-06-30
IL86151A0 (en) 1988-11-15
EP0288978B1 (de) 1992-11-04
CA1309027C (en) 1992-10-20
DK226688A (da) 1988-10-28

Similar Documents

Publication Publication Date Title
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATA68386A (de) Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten
DE3585607D1 (de) Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet.
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
FI890311A0 (fi) Kemiska foereningar.
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE3785740D1 (de) Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
DE69420679D1 (de) Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
PT86859A (pt) Process for the preparation of 9-ethyl-6,9-di-hydro-4,6-dioxo-10-propyl-4h-pyrano]3,2-g"-quinoline-2,8-calcium dicarboxilate and of pharmaceutical compounds containing it
ATE81974T1 (de) Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums.
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
EP0370454A3 (en) Renin-inhibiting amino diol derivatives
ATE121623T1 (de) Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie.
DE3777709D1 (de) Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis.
DE69529070D1 (de) Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv
DE3876448D1 (de) Verwendung eines tripeptids zur herstellung einer pharmazeutischen zusammensetzung sowie eine pharmazeutische zusammensetzung und methode.
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.